Form EFFECT - Notice of Effectiveness:
SEC Accession No. 9999999995-20-003447
Accepted
2020-12-09 00:15:25
Documents
1
Effectiveness Date
2020-12-08
Registration Form
S-3

Document Format Files

Seq Description Document Type Size
1 primary_doc.html EFFECT  
1 primary_doc.xml EFFECT 596
  Complete submission text file 9999999995-20-003447.txt   1926
Mailing Address 4747 EXECUTIVE DRIVE SUITE 210 SAN DIEGO CA 92121
Business Address 4747 EXECUTIVE DRIVE SUITE 210 SAN DIEGO CA 92121 858-200-3830
Odonate Therapeutics, Inc. (Filer) CIK: 0001717452 (see all company filings)

EIN.: 822493065 | State of Incorp.: DE | Fiscal Year End: 1231
Type: EFFECT | Act: 33 | File No.: 333-250993 | Film No.: 201376818
SIC: 2834 Pharmaceutical Preparations